Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis

Journal of Hepatology

Volumn 50, Issue 5, 2009, Pages 923-928

  Ripoll, Cristina ^a,b   Groszmann, Roberto J ^a,b   Garcia Tsao, Guadalupe ^a,b   Bosch, Jaime ^c,d   Grace, Norman ^e,f   Burroughs, Andrew ^g   Planas, Ramon ^d,h   Escorsell, Angels ^c,d   Garcia Pagan, Juan Carlos ^c,d   Makuch, Robert ^b   Patch, David ^g   Matloff, Daniel S ^f  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL CLÍNIC   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f Brigham and Women's/Faulkner Hospitals   (United States)

^g ROYAL FREE HOSPITAL   (United Kingdom)

^h Germans Trias i Pujol Foundation   (Spain)

Author keywords

Albumin; End stage liver disease; Liver cancer; Multivariate analysis; Portal hypertension; Predictive factors

Indexed keywords

ALBUMIN; PLACEBO; TIMOLOL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER INCIDENCE; CANCER RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HAZARD RATIO; HEPATIC VEIN; HEPATITIS C; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER HEMORRHAGE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PREDICTION; PREDICTOR VARIABLE; PRESSURE GRADIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ROC CURVE; UNIVARIATE ANALYSIS; VARICOSIS; VENOUS PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VARICOSE VEINS; VENOUS PRESSURE;

EID: 64549121063     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.01.014     Document Type: Article

References (17)

1. Fattovich G., Stroffolini T., Zagni I., and Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127 5 Suppl 1 (2004) S35-S50
2. D'Amico G., Garcia-Tsao G., and Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44 (2006) 217-231
3. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
4. Sherman M. Alphafetoprotein: an obituary. J Hepatol 34 (2001) 603-605
5. Bruix J., and Llovet J.M. HCC surveillance: who is the target population?. Hepatology 37 (2003) 507-509
6. Zhang B.H., Yang B.H., and Tang Z.Y. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130 (2004) 417-422
7. Velazquez R.F., Rodriguez M., Navascues C.A., Linares A., Perez R., Sotorrios N.G., et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 37 (2003) 520-527
8. Degos F., Christidis C., Ganne-Carrie N., Farmachidi J.P., Degott C., Guettier C., et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 47 (2000) 131-136
9. Ripoll C., Groszmann R., Garcia-Tsao G., Grace N., Burroughs A., Planas R., et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 133 (2007) 481-488
10. Groszmann R.J., Garcia-Tsao G., Bosch J., Grace N.D., Burroughs A.K., Planas R., et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 353 (2005) 2254-2261
11. Bruix J., Sherman M., Llovet J.M., Beaugrand M., Lencioni R., Burroughs A.K., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35 (2001) 421-430
12. Sangiovanni A., Prati G.M., Fasani P., Ronchi G., Romeo R., Manini M., et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 43 (2006) 1303-1310
13. Solà R., Alvarez M., Ballesté B., Montoliu S., Rivera M., Miguel M., et al. Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients. Liver Int 26 (2006) 62-72
14. Lee J.S., Semela D., Iredale J., and Shah V.H. Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?. Hepatology 45 (2007) 817-825
15. Dalgleish A.G., and O'Byrne K. Inflammation and cancer: the role of the immune response and angiogenesis. Cancer Treat Res 130 (2006) 1-38
16. Mazzanti R., Messerini L., Monsacchi L., Buzzelli G., Zignego A.L., Foschi M., et al. Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis. Hepatology 25 (1997) 229-234
17. Salcedo X., Medina J., Sanz-Cameno P., Garcia-Buey L., Martin-Vilchez S., Borque M.J., et al. The potential of angiogenesis soluble markers in chronic hepatitis C. Hepatology 42 (2005) 696-701